| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |